Biopsy + Cystoscopy + Bone Scan + Digital Rectal Examination + MRI-Guided Transurethral Ultrasound Ablation + Multiparametric Magnetic Resonance Imaging + PSMA PET Scan + Questionnaire Administration for prostatic neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 30 Jun 2022: Trial registered, NCT05438563

The trials

NCT05438563: MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer

State
Under way
Phase
No phase
People
100 planned
Started
6 Apr 2022
Primary completion
7 Jul 2028
Arms
Treatment (MRI-guided TULSA)
Results
None posted
  1. 6 Apr 2022: Trial started
  2. 30 Jun 2022: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.